Varicella zoster meningitis following COVID-19 vaccination: a report of two cases
Marturod Buranasakda, Praew Kotruchin, Kittisap Phanthachai, Piroon Mootsikapun, Ploenchan Chetchotisakd
Abstract
Most of the adverse effects reported in patients who have received COVID-19 vaccines have been mild. However, possible serious adverse effects are being monitored cautiously. There have also been a number of case reports of reactivation of varicella zoster infection within 28 days after immunization with mRNA COVID-19 vaccines. A few cases have also been reported after viral vector and inactivated COVID-19 vaccination. The incidence of meningitis following varicella zoster virus infection is rare. In the current study, we report two cases of male patients who received two different types of COVID-19 vaccine (inactivated and viral vector) and developed varicella zoster meningitis within 10 days after vaccination.